Sharanjit Kaur et al. 2021. Effectiveness of Trimetazidine, a Cytoprotective Agent in Ischemic Heart Disease. Technological Innovation in Pharmaceutical Research Vol. 6. (Jun. 2021), 65–72. DOI:https://doi.org/10.9734/bpi/tipr/v6/10092D.